(Q34477924)

English

New viral vaccines.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16364754%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

Europe PubMed Central

New viral vaccines (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16364754%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Harry B. Greenberg

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16364754%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1

object named as

Ann M Arvin

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16364754%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

language of work or name

0 references

publication date

1 January 2006

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16364754%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

Europe PubMed Central

2 August 2017

344

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16364754%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16364754%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

240-249

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16364754%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Varicella vaccine: genesis, efficacy, and attenuation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Current status of live attenuated influenza virus vaccine in the US.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Rotavirus antigenaemia and viraemia: a common event?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

The causal relation between human papillomavirus and cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Humoral and cell-mediated immunity to vero cell-derived influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Priming of human papillomavirus type 11-specific humoral and cellular immune responses in college-aged women with a virus-like particle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Challenges for rotavirus vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Immunology of papillomavirus infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Live-attenuated varicella vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Neurologic complications of the reactivation of varicella-zoster virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Varicella-zoster virus-specific immunity after herpes zoster

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Analysis of the frequencies and of the memory T cell phenotypes of human CD8+ T cells specific for influenza A viruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

A DNA transfection system for generation of influenza A virus from eight plasmids

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Multiple gene segments control the temperature sensitivity and attenuation phenotypes of ca B/Ann Arbor/1/66.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Spontaneous regression of CIN and delayed-type hypersensitivity to HPV-16 oncoprotein E7.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Influenza: lessons from past pandemics, warnings from current incidents.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Use of active surveillance to validate international classification of diseases code estimates of rotavirus hospitalizations in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Novel generations of influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Seasonality and diversity of Group A rotaviruses in Europe

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

A controlled trial of a human papillomavirus type 16 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Varicella-Zoster virus pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu mouse model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Decline in Varicella‐Zoster Virus (VZV)–Specific Cell‐Mediated Immunity with Increasing Age and Boosting with a High‐Dose VZV Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Mechanisms of human papillomavirus-induced oncogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Against which human papillomavirus types shall we vaccinate and screen? The international perspective

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Intussusception among infants given an oral rotavirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Reappraisal of the Association of Intussusception with the Licensed Live Rotavirus Vaccine Challenges Initial Conclusions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Generation of influenza A viruses entirely from cloned cDNAs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Decline in mortality due to varicella after implementation of varicella vaccination in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

The future of rotavirus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

A millennium update on pediatric diarrheal illness in the developing world

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Influenza vaccines: present and future

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Global Illness and Deaths Caused by Rotavirus Disease in Children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Effect of rotavirus vaccination programme on trends in admission of infants to hospital for intussusception.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

More on RotaShield and intussusception: the role of age at the time of vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Rotavirus infection in infants as protection against subsequent infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Efficacy of RIX4414 live attenuated human rotavirus vaccine in Finnish infants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Varicella-zoster virus infection of human dorsal root ganglia in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Papillomaviruses and cancer: from basic studies to clinical application

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

Pathogenesis of rotavirus gastroenteritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.057

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34477924&oldid=1970079229"